Cover image of the article: Adipsic Diabetes Insipidus: A Single-Center Case Series

Image Credit:Nephro-Urol Mon

Adipsic Diabetes Insipidus: A Single-Center Case Series

Authors

Foroogh Sabzghabaei1,*, Mahsa Akhtar2, Seyed Mahmoud Ramak Hashemi3, Reza MollahoseiniReza Mollahoseini ORCID4

Abstract

Adipsic diabetes insipidus (ADI) is a rare and challenging complication secondary to several neurosurgical procedures. It can lead to severe hyperosmolarity and is associated with high rates of morbidity and mortality. Considering the variable time of thirst sensation recovery, long-term treatment is accompanied with the risk of extreme extracellular osmolality fluctuations. Herein, we report 3 cases of this rare presentation of hypothalamic injury.

Highlights

How to Cite:Sabzghabaei F, Akhtar M, Ramak Hashemi SM, Mollahoseini R. Adipsic Diabetes Insipidus: A Single-Center Case Series. Nephro-Urol Mon. 2018;10(1):e14264. doi: https://doi.org/10.5812/numonthly.14264

1. Introduction

The occurrence of diabetes insipidus (DI) following neurosurgical procedures for brain tumors may be transient or permanent (1). Adipsia rarely accompanies DI (ADI) due to osmoreceptor destruction. These patients become easily dehydrated and are at a high risk of fluid and electrolyte disorders (2). ADI is often associated with significant hypothalamic dysfunction and complications, such as obesity, sleep apnea, thermoregulatory disorders, seizure, venous thromboembolism, and muscle dysfunction (3-5).
Herein, we present our experiences in the management of 3 rare cases of ADI following neurosurgical procedures.

2. Case Presentation

2.1. Case 1

A 68-year-old female patient underwent total transsphenoidal resection of pituitary adenoma. On the first postoperative day, the urine output was about 9 L with an osmolality equal to 175 mosmol/kg. After 2 days, the sodium (Na) level increased to 160 - 175 mEq/L (Table 1), while blood pressure remained normal; the patient also showed mild tachycardia. Other serum electrolytes, such as potassium, calcium, magnesium, and blood sugar, were in the normal range.
Despite high serum osmolality and full consciousness, the patient showed no desire to drink water. Desmopressin and fixed water intake were administered with the diagnosis of ADI. After 3 days, the urine output and Na level were found to be in the normal range. In the regular 1-year follow-up, no recovery in thirst sensation was observed, whereas the patient showed a relatively stable serum Na and urine output with desmopressin and fixed water intake.

2.2. Case 2

A 30-year-old female with headache, blurred vision, and diagnosis of suprasellar craniopharyngioma underwent surgery. On the first postoperative day, she was conscious and hemodynamically stable with a urine output of 11 L, Na level of 170 mEq/L (preoperative Na level, 144 mEq/L), potassium level of 3.8 mEq/L, and calcium level of 8.7 mg/dL. She showed no desire to drink water, and treatment was initiated with desmopressin and regular water intake, regardless of adipsia. One week later, the urine output was 2400 ml/day, and Na level decreased to 122 mEq/L. Subsequently, she started developing a sense of thirst. Treatment with desmopressin was ceased, and Na level recovered to normal (Table 1). After 3 years, she presented with permanent DI, requiring desmopressin to the same extent.
Table 1.
The Patients’ Characteristics and Laboratory Information
PatientPre OperationSecond Post-Operation DayAt Discharge
GCSSerum Sodium, Meq/LUrine Osmolality mosm,ol/kgSerum Creatinine, mg/dLGCSSerum Sodium, Meq/LUrine Osmolality, Mosmol/kgSerum Creatinine, mg/dLGCSSerum Sodium, Meq/LUrine Osmolality, Mosmol/kgSerum Creatinine, mg/dL
Patient 1 Female 68 years151439801.1151772800.9151444900.9
Patient 2 Female 30 years151458750.7151592400.8151413850.7
Patient 3 Male 57 years151301401.2151672351.3151405251.2

2.3. Case 3

A 57-year-old man presenting with severe headache was admitted with a diagnosis of intracranial hemorrhage. Upon admission, urine osmolality was 140 mosmol/kg, urine volume was 7300 mL/24 h, and serum Na level was 130 mEq/L. On the following day, he underwent surgery due to the aneurysm of anterior communicating artery. On the first postoperative day, Na level was 144 mEq/L and urine volume was normal. On the second day, polyuria appeared and Na level started increasing. On the third day, blood pressure dropped to 90 mmHg, without any evidence of bleeding or fluid loss. The urine volume decreased, and serum Na level increased to 167 mEq/L.
The patient was conscious, but had no thirst sensation. Accordingly, diagnosis of adipsia was confirmed. Treatment with intravenous hypoosmolar fluids and pure water was initiated. After 24 hours, blood pressure was 130/80 mmHg, and polyuria with diluted urine appeared (urine osmolality, 240 mosmol/kg). Therapy with desmopressin was started and after 2 days, thirst sensation recovered and DI disappeared.

3. Discussion

ADI is a rare disorder, which is generally secondary to hypothalamic lesions (6). It is attributed to the loss of thirst reflex due to surgical trauma to lamina terminalis, where the osmoreceptor neurons are located (7-9). Limited studies have reported a significantly higher risk of morbidity and mortality in ADI patients (2, 9, 10). Therefore, early diagnosis of this disorder in patients with neurosurgical interventions near the hypophysis or hypothalamus is critical.
In almost all cases, including our patients, diagnosis is based on the evaluation of thirst sensation while the patient is awake and hypernatremic. In these cases, water deprivation test is not required for diagnosis. Increased morbidity may be due to treatable hypothalamic abnormalities, such as obesity, sleep apnea, seizure, and thermoregulatory disorders, which should be examined in patients. One of the limitations of the present study was that we did not evaluate the patients for these disorders.
An interesting point about our patients was the recovery time of thirst sensation. In comparison with case No. 1, who was diagnosed with permanent pituitary adenoma and adipsia, recovery was faster in the other 2 patients. This finding is in contrast to our speculations and previous reports, which suggest that damage to anterior and posterior hypophysis in craniopharyngioma management is more severe than in other surgical interventions causing ADI (1). Management of ADI is generally challenging, as the time of adipsia recovery is variable, and central DI persists despite adipsia recovery. Detection of improvement and treatment cessation are important factors since fatal Na disorders may occur in this period.
In summary, delayed diagnosis of ADI, given the rare nature of this disease, leads to severe complications of the hyperosmolar state (11). Routine adipsia evaluation, combined with water deprivation and vasopressin tests (if necessary), is critical for the diagnosis and treatment of ADI. The fluid intake in patients diagnosed with ADI should be supervised daily, based on the constant volume of oral fluids, daily measurement of fluid balance, body weight, and sodium level (12), especially in patients who are physically unable to care for themselves.

3.1. Conclusions

ADI is a rare and challenging condition to manage. Therefore, careful monitoring and a high index of suspicion are required for its detection. The variable time of recovery in adipsia and DI is the most important issue, especially in the chronic management of patients.

References

  • 1.
    Gonzalez Briceno L, Grill J, Bourdeaut F, Doz F, Beltrand J, Benabbad I, et al. Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndrome. Horm Res Paediatr. 2014;82(6):364-71. [PubMed ID: 25377653]. https://doi.org/10.1159/000368401.
  • 2.
    Arima H, Wakabayashi T, Nagatani T, Fujii M, Hirakawa A, Murase T, et al. Adipsia increases risk of death in patients with central diabetes insipidus. Endocr J. 2014;61(2):143-8. [PubMed ID: 24212879].
  • 3.
    Sabzghabaei F, Rastegar A. Adipsic hypernatremic myopathy. Iran J Kidney Dis. 2015;9(3):256-8. [PubMed ID: 25957431].
  • 4.
    Smith D, McKenna K, Moore K, Tormey W, Finucane J, Phillips J, et al. Baroregulation of vasopressin release in adipsic diabetes insipidus. J Clin Endocrinol Metab. 2002;87(10):4564-8. https://doi.org/10.1210/jc.2002-020090.
  • 5.
    Miljic D, Miljic P, Doknic M, Pekic S, Stojanovic M, Petakov M, et al. Adipsic diabetes insipidus and venous thromboembolism (VTE): recommendations for addressing its hypercoagulability. Hormones (Athens). 2014;13(3):420-3. [PubMed ID: 25079469]. https://doi.org/10.14310/horm.2002.1496.
  • 6.
    Verdin E, Smitz S, Thibaut A, Born J, Legros JJ, Luyckx A. Adipsic hypernatremia in a patient with pseudotumor cerebri and the primary empty sella syndrome. J Endocrinol Invest. 1985;8(4):369-72. [PubMed ID: 4067208].
  • 7.
    Macias Batista A, Martinez Martin FJ, de Pablos Velasco PL. [Diabetes insipidus and adipsic hypernatremia in a patient with a craniopharyngioma]. An Med Interna. 1999;16(2):87-8. [PubMed ID: 10193001].
  • 8.
    Colleran K, Sanchez Goettler L, Sloan A. Hypothalamic obesity complicated by adipsic central diabetes insipidus following surgical resection of a craniopharyngioma. J Clin Hypertens. 2009;11(10):608-10. https://doi.org/10.1111/j.1751-7176.2009.00057.x.
  • 9.
    Raghunathan V, Dhaliwal MS, Gupta A, Jevalikar G. From cerebral salt wasting to diabetes insipidus with adipsia, case report of a child with craniopharyngioma. J Pediatr Endocrinol Metab. 2015;28(3):323-6. https://doi.org/10.1515/jpem-2014-0224.
  • 10.
    Zantut-Wittmann DE, Garmes HM, Panzan AD, Lima Mde O, Baptista MT. Severe rhabdomyolysis due to adipsic hypernatremia after craniopharyngioma surgery. Arq Bras Endocrinol Metabol. 2007;51(7):1175-9. [PubMed ID: 18157396].
  • 11.
    Hu MM, Liu M, Liu W. [Diagnosis and treatment of adipsic diabetes insipidus accompanied with intracranial calcification]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35(2):161-5. [PubMed ID: 23643004]. https://doi.org/10.3881/j.issn.1000-503X.2013.02.007.
  • 12.
    Janus DM, Wojcik M, Zygmunt-Gorska A, Wyrobek L, Urbanik A, Starzyk JB. Adipsic diabetes insipidus in pediatric patients. Indian J Pediatr. 2014;81(12):1307-14. [PubMed ID: 24788913]. https://doi.org/10.1007/s12098-014-1421-8.

Copyright

Copyright © 2017, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

30
Apr
2010
Transient diabetes insipidus in a woman with a twin pregnancy: A case report

Transient diabetes insipidus in a woman with a twin pregnancy: A case report

Amir Bahrami,
Amir Bahrami,
Farzad Najafipoor,
Majid Mobassery

Bahrami A, Bahrami A, Najafipoor F, Mobassery M. Transient diabetes insipidus in a woman with a twin pregnancy: A case report. Int J Endocrinol Metab. 2010;8(2):. doi:

31
Oct
2016
Association of Insulinoma and Type 2 Diabetes Mellitus

Association of Insulinoma and Type 2 Diabetes Mellitus

Hassan Ouleghzal,
Tarik Ziadi,
Mohammed Menfaa,
Soumia Safi

Ouleghzal H, Ziadi T, Menfaa M, Safi S. Association of Insulinoma and Type 2 Diabetes Mellitus. Int J Endocrinol Metab. 2017;15(1):e13275. doi: https://doi.org/10.5812/ijem.39439

2
Jul
2022
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

Nabil W. G. Sweis,
Ahmad Albanna,
Rama Alhasoun,
Ayman Zayed

Sweis NWG, Albanna A, Alhasoun R, Zayed A. A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases. Int J Endocrinol Metab. 2022;20(3):e126350. doi: https://doi.org/10.5812/ijem-126350

29
May
2016
Insulin Edema in Type 1 Diabetes Mellitus: Report of a Case and Brief Review of the Literature

Insulin Edema in Type 1 Diabetes Mellitus: Report of a Case and Brief Review of the Literature

Ayse Derya Bulus,
Nesibe Andiran,
Ali Osman Köksal

Derya Bulus A, Andiran N, Osman Köksal A. Insulin Edema in Type 1 Diabetes Mellitus: Report of a Case and Brief Review of the Literature. Inn J Pediatr. 2016;26(4):e5077. doi: https://doi.org/10.5812/ijp.5077

22
Jun
2026
Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report

Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report

Seyed Alireza Seyed Siamdoust,
Behrooz Zaman,
Taymaz Amiraslani,
Samad Noorizad,
Selda Zahedi,
Mohammad Reza Akhoondinasab

Seyed Siamdoust SA, Zaman B, Amiraslani T, Noorizad S, Zahedi S, et al. Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report. J Cell Mol Anesth. 2026;11(2):e171715. doi: https://doi.org/10.5812/jcma-171715

More by these authors

Foroogh SabzghabaeiPubMedScholar
Mahsa AkhtarPubMedScholar
Seyed Mahmoud Ramak HashemiPubMedScholar
Reza MollahoseiniPubMedScholar
Share
Cited by
Metrics
Indexed in